For comments, suggestions
Created with Raphaël 2.1.0 26.01.2016 Filing date 28.08.2017 Validation fee payment 28.02.2018 (A1) Patent application published 03.07.2023 AGEPI application filing date 30.09.2023 (T2) Translation of the validated European patent 26.04.2025 26.01.2026 Valid until 27.01.2027 Renewal fee to be paid until 26.01.2036 Patent will expire on

Patent in force


(210)Number of the EPO application16701516
(220)Filing date of the EPO application2016.01.26
(80)EPO patent specification publication (B)EPB nr. 17/2023, 2023.04.26
(110)EPO patent number3250182
(11)Number of the documentMD 3250182 T2
(21)Number of the applicatione 2017 0303
(71)Name(s) of applicant(s), code of the countryJANSSEN PHARMACEUTICA NV, BE;
(72)Name(s) of inventor(s), code of the countryGUPTA Manish Kumar, IN;
MARATHE Shripad Wasudeo, IN;
TAMBWEKAR Kaustubh Ramesh, IN;
NAIR Shreedevi Velayudhan, IN;
(73)Name(s) of owner(s), code of the countryJANSSEN PHARMACEUTICA NV, BE;
(54)Title of the inventionDispersible compositions
(13)Kind-of-document code T2
(51)International Patent Classification A61K 9/00 (2006.01.01); A61K 9/20 (2006.01.01); A61K 45/06 (2006.01.01); A61K 31/47 (2006.01.01); A61P 31/06 (2006.01.01); A61P 43/00 (2006.01.01)
(19)CountryBE
(41)Date of publication of the application2018.02.28
(49)Date of publication of the translation of the validated European patent specification2023.09.30
(30)Priority264MU2015, 2015.01.27, IN
(74)Patent attorney(Procedură) LAZICOV Tatiana, str. A. Pușkin nr. 33, ap. 73, MD-2012, Chișinau, Republica Moldova
(86)International applicationPCT/EP2016/051545, 2016.01.26
(87)International publicationWO 2016/120258, 2016.08.04
Up
/Inventions/details/3250182